Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PSI CRO Pharma India Private Limited is the Indian subsidiary of PSI CRO AG, a privately-owned, full-service global contract research organization (CRO). Established in 2008 and headquartered in Bangalore, the company supports global clinical trials by providing clinical monitoring, project management, and regulatory services in India. PSI CRO specializes in managing pivotal Phase 2 and Phase 3 clinical trials across key therapeutic areas, including oncology, hematology, gastroenterology, infectious diseases, and rare diseases. The company is known for its high-quality, on-time clinical trial delivery and predictable patient enrollment, leveraging local expertise to expedite study startup times in the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PSI CRO Pharma India.